Latest Updates on Availability for Wegovy pill
Interest in oral GLP-1 treatments has grown rapidly over the past year, and the Wegovy pill has become one of the most searched topics in UK weight management. As the first daily tablet version of semaglutide, it represents an important step forward for patients who want the proven results of Wegovy without a weekly injection.
The MHRA has now approved the Wegovy pill for use in the UK, but many people are still asking exactly what this means for them. Does approval mean the tablet is available to buy right away? Will it be offered privately, or only through the NHS? And is it safe to source online?
| Item | Current position |
| MHRA approval status | Approved |
| Private availability | Available through regulated UK providers from 1 July 2026 |
| NHS availability | Subject to separate NICE evaluation and commissioning processes |
| Prescription required | Yes |
| Last reviewed | 13th June 2026 |
Interested in the Wegovy Tablet?
Be among the first to hear when the Wegovy tablet becomes available in the UK. Register your interest today to receive updates on launch dates, pricing, eligibility criteria, and expert guidance from The Family Chemist.
Register Interest
Has the Wegovy Pill been approved in the UK?
Yes. The Wegovy pill (oral semaglutide) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA), the body responsible for assessing the safety, quality and effectiveness of medicines before they can be prescribed in the UK. You can read the official announcement on the GOV.UK website.
This approval is significant because it marks the first time a GLP-1 medicine for weight management has been available in tablet form in the UK. Until now, patients seeking treatment with semaglutide for weight loss have only had access to it as a weekly injection. A daily tablet removes the need for needles altogether, which may make treatment more accessible and appealing for people who have been put off by injectable options.
The approval was based on results from the OASIS 4 clinical trial, which assessed the safety and effectiveness of the tablet form of semaglutide in adults living with obesity or overweight. The trial findings, along with wider analysis of what this approval means for prescribing in the UK, have also been discussed in the BMJ.
For patients, MHRA approval is an important first step. It confirms that the medicine has met the regulatory standards required for use in the UK and opens the door for it to be prescribed through appropriate channels. It expands the range of treatment options available for weight management, giving patients and prescribers more flexibility when deciding on the right approach for an individual’s needs.
Don't want to wait? Wegovy injections are available now to buy.
Can you buy the Wegovy pill in the UK?
Following MHRA approval, the Wegovy pill is being made available through regulated UK providers from 1 July 2026. As with any newly launched medicine, exact availability can vary in the early weeks depending on stock allocation and how quickly individual providers roll out their services, so it is always worth checking directly with your chosen provider for the latest position.
It is also important to understand that the Wegovy pill is a prescription-only medicine. This means it cannot simply be bought over the counter or ordered online without a prior consultation. To access treatment, patients will need to complete an assessment with a healthcare professional, who will confirm whether the medicine is suitable based on factors such as BMI and overall health.
For full details on dosing, side effects and safety information, the Patient Information Leaflet (PIL) is available via the electronic Medicines Compendium.
If you are interested in starting treatment with the Wegovy pill, the best way to stay informed is to register with a regulated pharmacy or weight loss provider, who will be able to confirm current availability and talk you through the next steps once the service is live.
Interested in the Wegovy Tablet?
Register InterestWhat does MHRA approval actually mean?
MHRA approval is an important milestone, but it is easy to misunderstand what it actually changes for patients. Understanding the difference between before and after approval can help make sense of how new medicines move from development into everyday use.
Before a medicine receives MHRA approval, it cannot be marketed for that particular use, even if it has already been approved for other indications or in other countries. Pharmacies and healthcare providers are also unable to routinely prescribe it for that purpose, regardless of how promising the early evidence might look. This is because the MHRA’s role is to independently assess the safety, quality and effectiveness of a medicine for a specific use, based on rigorous clinical trial data, before it can be recommended for patients.
Once approval has been granted, the picture changes. The medicine may become available through regulated channels, meaning pharmacies and prescribers who meet the necessary clinical and regulatory standards can begin to offer it as part of their services. Approval does not mean that every provider will introduce the treatment immediately. Each provider needs to ensure they have the right clinical pathways, staff training and processes in place before offering a new medicine safely.
In short, MHRA approval opens the door to a medicine being prescribed, but it is down to individual healthcare providers to decide when and how they introduce it into their services. This distinction between approval and access is one of the most common sources of confusion for patients following news about new treatments.
“The MHRA approval of the Wegovy tablet marks a significant milestone in obesity treatment and opens a new chapter in weight management. Expanding access beyond injections gives patients greater choice and flexibility. This is an encouraging step forward in supporting long-term health outcomes for people living with obesity.”
Sunny Dhain MPharmRS PGDip IndP
Should you buy the Wegovy Pill Online?
The Wegovy pill is a prescription-only medicine, which means it should never be available to purchase without an appropriate clinical assessment, regardless of where it is being sold. Any website offering to sell it without requiring a consultation or prescription should be treated as a red flag, and in many cases will be operating illegally.
Unfortunately, the period following a new medicine’s approval is often when unregulated sellers try to take advantage of growing public interest. These sites may advertise the Wegovy pill as available for immediate purchase, sometimes at unrealistically low prices, with no consultation required. Buying from a source like this is not only illegal, it is also dangerous. Products sold this way may be counterfeit, contain incorrect dosages, or have been stored and transported incorrectly, all of which can affect their safety and effectiveness. There is also no clinical oversight to confirm the medicine is appropriate for you, which removes an important safeguard for a medicine that requires careful dose escalation and monitoring.
Buying through a regulated UK pharmacy, such as The Family Chemist, ensures that a qualified healthcare professional has reviewed your suitability for treatment, taking into account your medical history, current medications and any underlying health conditions. Regulated providers source their medicines through legitimate UK supply chains, so you can be confident that what you receive is genuine and safe to use.
To check whether a pharmacy is operating legitimately, look for its General Pharmaceutical Council (GPhC) registration number, which should be clearly displayed on the website, or search the GPhC register directly.
At The Family Chemist, we are preparing to offer the Wegovy pill through our regulated pharmacy service once it becomes available. If you are interested in this treatment, you can register your interest in the Wegovy pill and we will keep you updated as availability is confirmed, ensuring you are among the first to know when you can book a consultation.
What should patients do next?
Following approval, a number of steps typically take place before a new medicine becomes widely available.
| Milestone | What to look for |
| Prescribing information published | Full clinical guidance for healthcare professionals, including dosing and safety information |
| UK pricing confirmed | Manufacturer confirms private pricing; pharmacies begin publishing costs |
| Pharmacies confirm readiness | Regulated providers announce when they can begin prescribing |
| NICE review begins | NICE publishes scope or timeline for assessing the medicine for NHS use |
| NHS prescribing pathway | NICE guidance issued and NHS commissioners implement access criteria |
If you are interested in the Wegovy pill, there are a few practical steps you can take while you wait for it to become more widely available.
The most useful thing you can do is stay informed. Availability of newly approved medicines can change as providers introduce their services, so checking back regularly with a regulated pharmacy will ensure you have the most current information when it comes to access, eligibility and next steps.
It is also worth considering a discussion with a healthcare professional about your suitability for treatment. A consultation can help clarify whether the Wegovy pill is likely to be an appropriate option for you based on your BMI and medical history, so that you are ready to move forward as soon as it becomes accessible. You can find more detail on what to expect in our Wegovy tablet UK guide, which covers eligibility, dosing and what the treatment involves.
If you would prefer not to wait, the weekly Wegovy injection is already available through regulated providers and has a well-established track record for weight management. For some patients, starting with the injectable form and transitioning to the tablet later may be a suitable option, and this is something you can discuss during a consultation.
To stay up to date and be among the first to know when the Wegovy pill becomes available, register your interest here. Once the tablet is launched, this same page will allow you to complete an assessment and begin a consultation if treatment is considered suitable for you.
FAQs
- Is the Wegovy pill approved in the UK? The Wegovy pill has received MHRA approval for weight management in eligible adults, making it the first oral GLP-1 medicine licensed for this use in the UK.
- Can you buy the Wegovy pill in the UK? The Wegovy pill is being made available through regulated UK providers from 1 July 2026. Availability may vary in the early weeks depending on provider readiness, so it is worth checking with a regulated pharmacy such as The Family Chemist for the latest position.
- Will I need a prescription? The Wegovy pill is a prescription-only medicine and can only be supplied following an appropriate clinical assessment.
- Will the Wegovy pill be available on the NHS? NHS availability follows separate evaluation and commissioning processes through NICE, which are independent of MHRA approval and private availability.
- Is it safe to buy the Wegovy pill online? Only obtain prescription medicines from regulated providers following an appropriate clinical assessment. Websites offering the Wegovy pill without a consultation should be avoided, as they may be operating illegally and supplying counterfeit or unsafe products.
- Where can I find the latest updates? Check reputable healthcare providers and official sources for current information. You can also register your interest with The Family Chemist to be notified as soon as availability is confirmed.
- Can you buy the Wegovy pill today? Not yet. The Wegovy pill has been approved by the MHRA but is set to become available through regulated providers from 1 July 2026.
- Can I buy the Wegovy pill yet? The Wegovy pill is not yet available to purchase, but you can register your interest now so you are notified as soon as it launches.
- How much will the Wegovy pill cost in the UK? Pricing has not yet been confirmed. Once providers begin offering the Wegovy pill, costs will be published on regulated pharmacy websites, including The Family Chemist’s Wegovy tablet page.
- Is the Wegovy pill available in the UK now? The Wegovy pill has been approved for use in the UK, but it is not yet available to patients. It is expected to become available through regulated providers from 1 July 2026.
- When will the Wegovy pill launch in the UK? The Wegovy pill is expected to launch in the UK on 1 July 2026, following MHRA approval.
- What happens next? Following approval, a number of steps typically take place before a new medicine becomes widely available. These include the publication of full prescribing information for healthcare professionals, confirmation of UK pricing by the manufacturer, and individual pharmacies announcing when they are ready to begin prescribing. Separately, NICE will need to review the medicine for potential NHS use, a process that runs independently of private availability and can take considerably longer. We will update this page as each of these milestones is reached.
- Can you buy the Wegovy pill online? The Wegovy pill can only be obtained online through a regulated pharmacy following a consultation. It cannot be purchased without a prescription, regardless of where it is advertised.
- Is the Wegovy pill the same as Rybelsus? Both the Wegovy pill and Rybelsus contain the same active ingredient, oral semaglutide, but they are licensed for different uses and are available at different doses. Rybelsus is licensed for managing type 2 diabetes, while the Wegovy pill is specifically licensed for weight management in adults with obesity or overweight with a related health condition.
- Who may be eligible for the Wegovy pill? The Wegovy pill is licensed for adults with a BMI of 30 or above, or adults with a BMI between 27 and 30 who have at least one weight-related health condition. Eligibility will be confirmed individually following a consultation with a healthcare professional.
- Why is the Wegovy pill 25mg when the injection is only 2.4mg? The two forms of semaglutide are not directly comparable by dose. Semaglutide is absorbed much less efficiently when taken as a tablet than when injected, so a significantly higher dose is needed orally to achieve a similar effect in the body.


